Side-by-side comparison of AI visibility scores, market position, and capabilities
Victor NY Mexican beer imports (NYSE: STZ) ~$9.8B FY2025 revenue; Modelo Especial #1 US beer brand since June 2023, Corona/Pacifico, wine portfolio review, competing with ABI and Molson Coors.
Constellation Brands, Inc. is a Victor, New York-based beer, wine, and spirits company — publicly traded on the New York Stock Exchange (NYSE: STZ) as an S&P 500 Consumer Staples component — producing and marketing the United States rights to Mexican beer brands including Modelo Especial, Corona Extra, Pacifico, and Modelo Negra (acquired from Anheuser-Busch InBev as a condition of ABI's 2013 Grupo Modelo acquisition), and a wine and spirits portfolio including Robert Mondavi, Kim Crawford, The Prisoner, Meiomi, and High West whiskey through approximately 10,000 employees. In fiscal year 2025 (ending February 2025), Constellation Brands reported revenues of approximately $9.8 billion, with the Beer Division (Modelo, Corona, Pacifico) generating approximately $8.4 billion (+4-5% organic growth) as Modelo Especial maintained its status as the #1-selling beer in the United States by dollar sales — a position Modelo captured from Bud Light in June 2023 following the Bud Light controversy and has held since. CEO Bill Newlands retired in 2024, with Garth Hankinson succeeding him, maintaining Constellation's strategy of investing behind the Modelo brand family's premium Hispanic-heritage positioning as the fastest-growing segment of US beer consumers (Hispanic adult beer drinkers choosing culturally authentic imported Mexican lagers over domestic brands). The Wine and Spirits segment faced significant headwinds from premiumization-to-value trading and market share pressure — Constellation announced a strategic review of the Wine and Spirits portfolio in 2024, exploring potential divestitures to focus capital exclusively on the Beer Division's high-margin, high-growth beer brands.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.